Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

Background. Using the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute and American total mortality rates, the authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and then subtracted the incidence of microscopic Stage A cancers too small to ever be clinically significant. This gave a final probability of 8%.

[1]  T. Stamey,et al.  Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.

[2]  T. Stamey,et al.  Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .

[3]  T. Stamey,et al.  The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate. , 1992, The Journal of urology.

[4]  T. Stamey,et al.  Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.

[5]  T. Stamey,et al.  Capsular Penetration in Prostate Cancer. Significance for Natural History and Treatment , 1990, The American journal of surgical pathology.

[6]  H. Levin,et al.  Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer , 1989, Cancer.

[7]  T H Beaty,et al.  Family history and the risk of prostate cancer , 1990, The Prostate.

[8]  T. Stamey,et al.  PATTERNS OF PROGRESSION IN PROSTATE CANCER , 1986, The Lancet.

[9]  L. Foulds.  The experimental study of tumor progression: a review. , 1954, Cancer research.

[10]  P. Scardino,et al.  The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. , 1991, The Journal of urology.

[11]  L. M. Franks.  Latent carcinoma of the prostate. , 1954, The Journal of pathology and bacteriology.

[12]  M. Listrom,et al.  Incidental carcinoma of the prostate: an analysis of the predictors of progression. , 1988, The Journal of urology.

[13]  T. Stamey,et al.  Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors , 1992, Cancer.

[14]  J. McNeal,et al.  Origin and development of carcinoma in the prostate , 1969, Cancer.

[15]  T. Stamey,et al.  Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. , 1990, The Journal of urology.

[16]  M. Mushinski,et al.  Probabilities of eventually developing or dying of cancer—united states, 1985 , 1985, CA: a cancer journal for clinicians.

[17]  M. Terris,et al.  Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. , 1991, The Journal of urology.

[18]  T. Stamey,et al.  Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.

[19]  H. Adami,et al.  NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.

[20]  Z. Hall.  Cancer , 1906, The Hospital.

[21]  M. Spitz,et al.  Familial patterns of prostate cancer: a case-control analysis. , 1991, The Journal of urology.